Lactate dehydrogenase A (LDHA) inhibitor, GNE-140 racemic, Purity ≥98%

Cat. No.: X24-09-YM579

Lactate dehydrogenase A (LDHA) inhibitor, GNE-140 racemic, Purity ≥98%

Synonym: 1809794-70-4; 3-((2-Chlorophenyl)thio)-4-hydroxy-6-(4-morpholinophenyl)-6-(thiophen-3-yl)-5,6-dihydropyridin-2(1H)-one; 5-(2-Chlorophenyl)sulfanyl-4-hydroxy-2-(4-morpholin-4-ylphenyl)-2-thiophen-3-yl-1,3-dihydropyridin-6-one; Lactate dehydrogenase A (LDHA) inhibitor

  • CAS Number: 1809794-70-4
  • Compound CID: 118384502
Product Size
1 g; 2 g; 5 g; 10 g
Price
Datasheet
MSDS
Properties
Description
GNE-140 racemic is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting lactate dehydrogenase A (LDHA). The molecular weight of the compound is 499.04, and its molecular formula is C25H23ClN2O3S2.
Molecular Weight
499.04
Molecular Formula
C25H23ClN2O3S2
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
GNE-140 racemic can be studied extensively for its potential therapeutic applications in the treatment of type 2 diabetes by enhancing insulin sensitivity and regulating glucose levels.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0